Adjuvant therapy of malignant ovarian tumors after organ preservation;Adjuvante Therapie bosartiger Ovarialtumoren nach Organerhalt

Zentralblatt fur Gynakologie

Volumn 118, Issue 10, 1996, Pages 565-570

  Schroder W ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

adjuvant therapy; malignant ovarian tumors; preservation of fertility

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

CANCER RISK; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; FEMALE FERTILITY; HUMAN; ORGAN PRESERVATION; OVARY CANCER; OVARY TUMOR; PROGNOSIS; ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER STAGING; CARCINOMA; DRUG EFFECT; FERTILITY; MORTALITY; NEOPLASM; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; FEMALE; FERTILITY; HUMANS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030333230     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Berek JS: Adjuvant Therapy For Early-Stage Ovarian Cancer. N Engl J Med 322 (1990) 1076-77
2. Bertelsen K, Holund B, Andersen JE, Nielsen K, Stroyer L Ladehoff P: Prognostic factors and adjuvant treatment in early epithelial ovarian cancer. Int J Gynecol Cancer 3 (1993) 211-218
3. Bolis G, Colombo N, Favalli G, Giardina G, Landoni F, Mangili G, Marsoni S, Scarfone D, Torri V, Zanaboni F, Mangioni C: Randomized Multicenter Clinical Trial in Stage I Epithelial Ovarian Cancer. Proc Am Soc Clin Oncol 11 (1992) 225
4. Bonazzi C, Peccatori F, Colombo N, Lucchini V, Cantù MG, Mangioni C: Pure Ovarian Immature Teratoma, a Unique and Curable Disease: 10 Years' Experience of 32 Prospectively Treated Patients. Obstet Gynecol 84 (1994) 598-604
5. Burghardt E, Girardi F, Lahousen M, Tamussino K, Stettner H: Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40 (1991) 103-106
6. Christman JE, Teng NNH, Lebovic GS, Sikic BI: Delivery of a Normal Infant following Cisplatin, Vinblastine, and Bleomycin (PVB) Chemotherapy for Malignant Teratoma of the Ovary during Pregnancy. Gynecol Oncol 37 (1990) 292-295
7. Colombo N, Chiari S, Maggioni A, Bocciolone L, Torri V, Mangioni C: Controversial Issues in the Management of Early Epithelial Ovarian Cancer: Conservative Surgery and Role of Adjuvant Therapy. Gynecol Oncol 55 (1994) 47-51
8. Curtin JP, Morrow CP, D'Ablaing G, Schlaerth JB: Malignant germ cell tumors of the ovary: 20-year report of LAC-USC Women's Hospital. Int J Gynecol Cancer 4 (1994) 29-35
9. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K: Prognostic Factors in Patients with Stage I epithelial ovarian cancer. Obstet Gynecol 75 (1990) 263-273
10. Finn CB, Luesley DM, Buxton EJ, Blackledge GR, Kelly K, Dunn JA, Wilson S: Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. Br J Obstet Gynaecol 99 (1992) 54-58
11. Gershenson DM: Update on Malignant Ovarian Germ Cell Tumors. Cancer 71 (1993) 1581-1590
12. Gershenson DM: Chemotherapy of Ovarian Germ Cell Tumors and Sex Cord Stromal Tumors. Semin Surg Oncol 10 (1994) 290-298
13. Germá JR, Izquierdo MA, Seguí MA, Climent MA, Ojeda B, Alonso C: Malignant Ovarian Germ Cell Tumors: The Experience at the Hospital de la Santa Creu i Sant Pau. Gynecol Oncol 45 (1992) 153-159
14. Heintz APM, Van Oosterom AT, Trimbos JBMC, Schaberg A, Van Der Velde EA, Nooy M: The Treatment of Advanced Ovarian Carcinoma (I): Clinical Variables Associated with Prognosis. Gynecol Oncol 30 (1988) 347-358
15. Kaern J, Tropé CG, Kristensen GB, Abeler VM, Pettersen EO: DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 3 (1993) 349-358
16. Lentz SS, Cha SS, Wieand HS, Podratz KC: Stage I Ovarian Epithelial Carcinoma: Survival Analysis following Definitive Treatment. Gynecol Oncol 43 (1991) 198-202
17. Lim-Tan SK, Cajigas HE, Scully RE: Ovarian cystectomy for Serous Borderline Tumors: A Follow-Up Study of 35 Cases. Obstet Gynecol 72 (1988) 775-780
18. Messing MJ, Gershenson DM, Morris M, Burke TW, Kavanagh JJ, Wharton JT: Primary treatment failure in patients with malignant ovarian germ cell neoplasms. Int J Gynecol Cancer 2 (1992) 295-300
19. Monga M, Carmichael JA, Shelley WE, Kirk ME, Krepart GV, Jeffrey JF, Pater JL: Surgery without Adjuvant Chemotherapy for Early Epithelial Ovarian Carcinoma after Comprehensive Surgical Staging. Gynecol Oncol 43 (1991) 195-197
20. Pfleiderer A: Die Erhaltung der Fertilität bei malignen Ovarialtumoren. Gynäkologe 21 (1988) 308-314
21. Pfleiderer A: Therapy of Ovarian Malignant Germ Cell Tumors and Granulosa Tumors. Int J Gynecol Pathol 12 (1993) 162-165
22. Rice LW, Berkowitz RS, Mark SD, Yavner DI, Lage JM: Epithelial Ovarian Tumors of Borderline Malignancy. Gynecol Oncol 39 (1990) 195-198
23. Saigo PE: The Histopathology of Malignant Ovarian Tumors. In: Cancer of the Ovary. Eds: Markman M, Hoskins WJ New York: Raven Press 1993, 21-46
24. Sarria JA, Ferreyra H, Diaz ME: Low Malignant Potential Ovarian Carcinoma: Conservative Surgery and Fertility. Int J Gynecol Cancer 5 (1995) Suppl. 1, 48
25. Schwartz PE, Chambers SK, Chambers JT, Kohorn E, Mcintosh S: Ovarian Germ Cell Malignancies: The Yale University Experience. Gynecol Oncol 45 (1992) 26-31
26. Tasker M, Langley FA: The outlook for women with borderline epithelial tumours of the ovary. Br J Obstet Gynaecol (1985) 969-973
27. Thigpen JT, Vance RB, Kansur T: Second-line chemotherapy for recurrent carcinoma of the ovary. Cancer 71 (1993) 1559-1564
28. Thomas GM, Dembo AJ, Hacker NF, De Petrillo AD: Current therapy for dysgerminoma of the ovary. Obstet Gynecol 70 (1987) 268-275
29. Trimble EL, Trimble CL: Epithelial Ovarian Tumors of Low Malignant Potential. In: Cancer of the Ovary. Eds: Markman M, Hoskins WJ. New York: Raven Press 1993, 415-429
30. Vergote IB, Vergote-De Vos LN, Abeler VM, Aas M, Lindegaard MW, Kjorstad KE, Tropé CG: Randomized Trial Comparing Cisplatin with Radioactive Phosphons or Whole-Abdomen Irradiation as Adjuvant Treatment of Ovarian Cancer. Cancer 169 (1992) 741-749
31. Vergote IB, Kaern J, Abeler VM, Pettersen EO, De Vos LN, Tropé CG: Analysis of Prognostic Factors in Stage I Epithelial Ovarian Carcinoma. Importance of Degree of Differentiation and Desoxyribunucleic Acid Ploidy in Predicting Relapse. Am J Obstet Gynecol 169 (1993) 40-52
32. Whitman GF; Nolan TE, Gallup DG: Normal Ovarian Development and Function. In: Cancer of the Ovary. Eds: Markman M, Hoskins WJ. New York: Raven Press 1993, 1-20
33. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P: Adjuvant Therapy of Ovarian Germ Cell Tumors With Cisplatin, Etoposide and Bleomycin: A Trial of the Gynecologic Oncology Group. J Clin Oncol 12 (1994) 701-706
34. Wu P-C, Huang R-L, Lang J-H, Huang H-F, Lian L-J, Tang M-Y: Treatment of Malignant Ovarian Germ Cell Tumors with Preservation of Fertility: A Report of 28 Cases. Gynecol Oncol 40 (1991) 2-6
35. Young RC: Management of Early Stage Ovarian Cancer. In: Cancer of the Ovary. Eds: Markman M, Hoskins WJ. New York: Raven Press 1993, 359-373
36. Young RC, Walton LA, Ellenberg SS, Homesley Hd, Wilbanks GD, Decker DG, Miller A, Park R, Major F: Adjuvant Therapy in Stage I and Stage II epithelial ovarian cancer. N Engl J Med 322 (1990) 1021-1027